Delivery Order SPE2DB22D2007-SPE2DB25FH8QE

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB25FZ20U, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,784.96, is a delivery order for the supply of 4566529414 - VYVANSE 10 MG CAPSULE 100S. The contract has a firm fixed price and an ultimate completion date of November 25, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
The federal contract award, SPE2DB25D2204|SPE2DB25FTFXT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,173.83 firm fixed-price delivery order contract, with a completion date of January 8, 2025, is for the supply of 4566861069 - VYVANSE 20 MG CAPSULE 100S. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, SPE2DX15D1053|SPE2DX25F6GPM, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,783.60, is a Firm Fixed Price delivery order for the supply of 4,567,025,850 units of VYVANSE 30 MG CAPSULE 100S. The contract has an ultimate completion date of January 23, 2025. This award is part of a larger...
This federal contract award, SPE2DB20D2104|SPE2DB25FMHHC, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,550.62 firm fixed-price delivery order is for the supply of 4,567,152,394 units of VYVANSE 70 MG CAPSULE 100S. The contract has an ultimate completion date of February 5, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB22D3004|SPE2DB24FNT83, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,464.72, is for the delivery of 4563152875 VYVANSE 30 MG CAPSULE 100S. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, with ID SPE2DX15D1022|SPE2DX25FVBAY, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $16,283.20 firm fixed-price delivery order is for the supply of 4566878330 - VYVANSE 60 MG CAPSULE 100S. The contract has an ultimate completion date of January 10, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award, with ID SPE2DB22D2206 and SPE2DB25FET99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,837.19 delivery order contract is for the supply of 4566769139 - VYVANSE 60 MG CAPSULE 100S, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of December 20, 2024. Amerisourcebergen holds a larger $999,999,999...
This federal contract award, with ID SPE2DB22D2006|SPE2DB24FW1ME, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,366.19, is a delivery order for the purchase of 100 units of the medication VYVANSE 70 MG CAPSULE. The contract is not designated as a set-aside. It is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award, with an ID of SPE2DB22D1202|SPE2DB24FVAW2, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the provision of 4564660026 - VYVANSE 60 MG CAPSULE 100S, a pharmaceutical product. The contract has a firm fixed price of $1,234.64 and a completion date of May 21, 2024. The contract is a delivery order and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award, valued at $10,830.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH8QE
    Delivery Order

This federal contract award, identified as SPE2DB22D2007|SPE2DB25FH8QE, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,023.52, is a delivery order with a firm fixed price and an ultimate completion date of January 30, 2025. The contract is for the supply of 4567089484 units of VYVANSE 60 MG CAPSULE 100S, a medication used in the treatment of various medical conditions. The contract does not have a set-aside designation, indicating it was open to competition. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/4/25, 12:57 AM